Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

← Back to the feed

UMANITEK AG

History from 11 Mar 2025

UID
CHE-171.163.797
Legal form
AG
Canton
ZG
Founded
11 Mar 2025
Amount raised
not in the SHAB
Lead investor
not in the SHAB
Nominal capital · CHFCHF 118k
29k59k88k118k30 Oct 2025 · CHF 115k3 Aug 2026 · CHF 118kRound announced 10 Feb 20262026
  • shares
  • round announced

Record

  1. Company formed

    Founded 11 Mar 2025

    SHAB HR01-1006282168 ↗
  2. Capital band adopted

    SHAB HR02-1006399825 ↗
  3. Capital increase

    Likely financing · possible confirmation

    Paid in cash

    Nominal capital
    105’000 → 115’318.10
    Shares
    1’050’000 → 1’153’181
    New shares, % of post-step shares
    8.9% (103’181 new)

    Aktienkapital neu: CHF 115'318.10 [bisher: CHF 105'000.00]. Liberierung Aktienkapital neu: CHF 115'318.10 [bisher: CHF 105'000.00]. Aktien neu: 1'153'181 vinkulierte Namenaktien zu CHF 0.10 [bisher: 1'050'000 vinkulierte Namenaktien zu CHF 0.10]. Ordentliche Kapitalerhöhung innerhalb des Kapitalbandes.

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5

    Classifier score 0.65 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006471188 ↗
  4. Round announced

    possible match · low match confidence

    Announcement ↗
  5. Capital increase

    Capital increased · undecided

    Paid in cash

    Nominal capital
    115’318.10 → 117’818.70
    Shares
    1’153’181 → 1’178’187
    New shares, % of post-step shares
    2.1% (25’006 new)

    Aktienkapital neu: CHF 117'818.70 [bisher: CHF 115'318.10]. Liberierung Aktienkapital neu: CHF 117'818.70 [bisher: CHF 115'318.10]. Aktien neu: 1'178'187 vinkulierte Namenaktien zu CHF 0.10 [bisher: 1'153'181 vinkulierte Namenaktien zu CHF 0.10]. Ordentliche Kapitalerhöhung innerhalb des Kapitalbandes.

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5

    Classifier score 0.45 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006722444 ↗

Published by 8 Oct 2026